BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SFL's Managing Director Invited to Speak at Drug Information Association 49th Annual Meeting in Boston


6/7/2013 9:54:30 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

June 7, 2013 -- SFL is pleased to announce that Shayesteh Fürst - Ladani , Managing Director of the company, has been invited as a panel member and give a presentation at the DIA 2012 49th Annual Meeting to be held June 23 - 27 at the Boston Convention and Exhibition Center in Boston, US.

Ms. Fürst - Ladani has been invited to spea k at the session “Co - development of Targeted Therapies and Companion Diagnostics: Identifying Regulatory Strategies to Overcome Challenges” on Tuesday, June 25 at 1:45 pm – 3:15 pm. In her presentation entitled “European regulatory oversight of companion dia gnostics”, Shayesteh will provide an overview of the latest developments of the European legislation on companion diagnostics (CDx) and explain potential implications for drug and IVD companies.

“This session will assist manufacturers in understanding the regulatory changes taking place for CDxs,” commented Shayesteh. “It will enable companies to learn about the practical implications of the new regulatory framework and understand what will be expected of them in the future in terms of meeting required stan dards.

Shayesteh is the Managing Director and founder of SFL. She has comprehensive experience in formulating global regulatory strategies and provides support for the development of drugs, orphan drugs, drug and device combination products, borderline pr oducts, medical devices, in vitro diagnostics and advanced therapy medicinal products.

Shayesteh is Chair of the Combination Products Topic Group at EuropaBio. She has been member of the Program Committee of DIA EuroMeeting for 2011, 2012, 2013 and 2014 le ading the Theme Drugs, Devices, In Vitro Diagnostics and their Combinations. In 2012 she received the Open University Business School’s Alumni Award Outstanding Contribution to an Organization.

For more information, please contact:

Faiz Kermani, PhD

Senior Communication Manager

SFL Regulatory Affairs & Scientific Communication Ltd

Hochstrasse 51,

CH - 4002 Basel,

Switzerland

Tel: +41 61 361 9443

Fax: +41 61 361 9442

Email: office@sfl - services.com

Web: www.sfl - services.com



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES